Le Lézard
Classified in: Health, Business
Subject: ERN

SciBase: Interim Report


STOCKHOLM, Aug. 21, 2018 /PRNewswire/ -- January 1 ? June 30, 2018

The second quarter in figures

The first half-year in figures

Important events during the quarter

Important events after the end of the period



Apr1 - June 30

Jan 1 - June 30

July 1 2017
-
June 30 2018

Jan 1 - Dec 31

THE GROUP

2018

2017

2018

2017

Rolling-12

2017

Net sales, SEK ths

1 571

2 046

3 510

3 801

6 568

6 859

Gross margin, %

58,2%

34,2%

51,7%

30,6%

46,8%

35,4%

Equity/Asset ratio, %

92,0%

87,2%

92,0%

87,2%

89,9%

90,5%

Net indebtness, multiple

0,09

0,15

0,09

0,15

0,11

0,11

Cash equivalents, SEK ths

85 231

60 974

85 231

60 974

85 231

110 015

Cashflow from operating activities, SEK ths

-10 119

-11 044

-19 801

-23 025

-40 955

-44 180

Earnings per share (before and after dilution), SEK

-0,62

-1,42

-1,20

-2,82

-3,09

-5,00

Shareholder's equity per share, SEK

5,76

8,38

5,76

8,38

7,80

13,63

Average number of shares, 000'

16 618

8 285

16 618

8 285

10 576

8 493

Number of shares at closing of period, 000'

16 618

8 285

16 618

8 285

16 618

16 618

Share price at end of period, SEK

6,45

19,08

7,45

19,08

7,45

7,80

Number of sold electrodes, pieces

4 304

5 232

8 438

9 328

15 814

16 704

Average number of employees

20

21

20

22

20

21

This information is information that SciBase Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out below, at 08.00 CET on August 21, 2018.

This interim report has not been subject to review by the Company's auditors. 

Contact person:

Michael Colérus, CFO

For more information, please contact: 

Simon Grant
CEO SciBase 
Phone: +46-72-887-43-99 
Email: [email protected]

About SciBase and Nevisense

SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed a unique point-of-care device for the accurate detection of malignant melanoma. Its product, Nevisense, helps doctors to detect malignant melanoma, the most dangerous type of skin cancer. SciBase was founded by Stig Ollmar, Associate Professor at The Karolinska Institute in Stockholm, Sweden. Nevisense is based on substantial research and has achieved excellent results in the largest clinical study ever conducted on the detection of malignant melanoma. Nevisense is CE marked in Europe, has TGA approval in Australia, and now also a FDA clearance in the United States. Nevisense is based on a method called Electrical Impedance Spectroscopy (EIS), which uses the varying electrical properties of human tissue to categorize cellular structures and thereby detect malignancies. SciBase is listed on Nasdaq First North ("SCIB"). Avanza is the certified advisor. Further information is available on www.scibase.com.

This information was brought to you by Cision http://news.cision.com

http://news.cision.com/scibase/r/interim-report,c2596416

The following files are available for download:

http://mb.cision.com/Main/12371/2596416/894537.pdf

PDF


These press releases may also interest you

at 05:45
The Gross Law Firm issues the following notice to shareholders of New York Community Bancorp, Inc. . Shareholders who purchased...

at 05:30
Cato Networks, the SASE leader, announced a new SASE throughput record here at the Porsche Studio Ginza ahead of the 2024 Tokyo E-Prix, achieving 10 Gbps without hardware upgrades. At 10 Gbps, Cato became the first SASE platform to compete not only...

at 05:00
TAL Education Group ("TAL" or the "Company") , a smart learning solutions provider in China, today announced that it will release its unaudited financial results for the fourth quarter and fiscal year 2024 ended February 29, 2024, before the market...

at 04:25
Ademi LLP is investigating Doma  for possible breaches of fiduciary duty and other violations of law in its transaction with Title Resources Group. ...

at 04:00
U Power Limited (the "Company" or "U Power"), a vehicle sourcing services provider with a vision to becoming a comprehensive EV battery power solution provider in China, today announced that the Company held an extraordinary general meeting of...

at 04:00
Tonight on BBC1, REMY founder Abeer Iqbal, entered the Den, and despite intense grilling and no investment, left with a six-figure job offer from Peter Jones. ...



News published on and distributed by: